Introduction
Financing a startup often involves more than just selling shares. Founders frequently use convertible instruments such as SAFEs (simple agreements for future equity), convertible promissory notes and warrants to raise capital before a priced equity round. Each method has distinct terms, valuation mechanics, and tax consequences.
Key topics covered on the blog
- Convertible notes vs. SAFEs — We compare convertible promissory notes and SAFEs, explaining when each might be appropriate and highlighting the risks of accumulating multiple instruments without a clear capitalization plan.
- Warrants: the tax story — Warrants give investors the right to purchase additional shares at a fixed price. The tax treatment differs depending on whether a warrant is issued for investment or as compensation; in the former case, no tax is due until exercise, while compensatory warrants can trigger ordinary income.
- Redemptions and QSBS — Certain redemptions can disqualify QSBS treatment. Before repurchasing founder shares or redeeming investors, ensure you understand the Section 1202 rules.
- Preferred stock and venture capital — We outline typical preferred stock terms such as liquidation preferences, pro rata rights and protective provisions, and discuss negotiating term sheets with venture capital investors.
Navigating early‑stage financings requires careful consideration of valuation, dilution and tax issues. We advise founders and investors on drafting SAFE and note documents, negotiating term sheets and structuring deals to align interests.
Ready to get started?
- Schedule a consultation — Book a time on our calendar to discuss your fundraising strategy.
- Contact us — Reach us through our contact page with your questions.
- Subscribe for updates — Join our newsletter to receive insights on startup financings, SAFEs, notes and warrants.